InsidersTradesSigma
申报总数
公司
▲ 买入（5 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
5
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Gower Bob G, 董事. Insider active across 1 company, notably Ensysce Biosciences, Inc.. Cumulatively, 6 filings have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €948k. Activity tracked since 9 December 2022. The latest transaction was filed on 23 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Gower Bob G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
508,614 股@ US$0.48422.2% 占其流量Common StockSEC:0001493152-26-038866:0
标准退出：2026年7月22日 (T+90)
400,000 股@ US$0.49518.1% 占其流量Common StockSEC:0001493152-26-038866:1
标准退出：2026年11月5日 (T+90)
90,287 股@ US$0.48837.3% 占其流量Common StockSEC:0001493152-23-006786:0
标准退出：2023年5月31日 (T+90)
109,300 股@ US$0.48838.9% 占其流量Common StockSEC:0001493152-23-006553:0
标准退出：2023年5月29日 (T+90)
357,143 股@ US$1.4083.8% 占其流量Common StockSEC:0001493152-23-003343:0
标准退出：2023年3月9日 (T+90)
7,919,026 股Common StockSEC:0001192482-21-000620:0
6 条申报中的 6 条
About Gower Bob G
Bob G. Gower is a board member of Ensysce Biosciences, Inc. In this role, he is involved in overseeing the company's operations and guiding its strategic direction. With experience in the biotechnology sector, he contributes to decision-making that impacts Ensysce's performance and growth. His expertise is a valuable asset to the company.
